Evidence map›Paper›PMID 25246270›Full record

ArticleNeoplasia (New York, N.Y.)2014

Human-gyrovirus-Apoptin triggers mitochondrial death pathway--Nur77 is required for apoptosis triggering.

Wiem Chaabane, Artur Cieślar-Pobuda, Mohamed El-Gazzah, Mayur V Jain, Joanna Rzeszowska-Wolny, Mehrdad Rafat, Joerg Stetefeld, Saeid Ghavami, Marek J Los

Open access · goldAbstract read
In one paragraph

Article in Neoplasia (New York, N.Y.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Phafins Are More Than Phosphoinositide-Binding Proteins.International journal of molecular sciences · 2023
    Review
  3. Article
  4. Article
  5. Apoptosis Triggered by ORF3 Proteins of theFrontiers in cellular and infection microbiology · 2020
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Wiem ChaabaneDepartment of Clinical and Experimental Medicine (IKE), Division of Cell Biology, and Integrative Regenerative Medicine Center (IGEN), Linköping University, Linköping Sweden; Department of Biology, Faculty of Sciences, Tunis University, Tunis, Tunisia.
Artur Cieślar-PobudaDepartment of Clinical and Experimental Medicine (IKE), Division of Cell Biology, and Integrative Regenerative Medicine Center (IGEN), Linköping University, Linköping Sweden; Inst. of Automatic Control, Silesian Univ. of Technology, Gliwice, Poland.
Mohamed El-GazzahDepartment of Biology, Faculty of Sciences, Tunis University, Tunis, Tunisia.
Mayur V JainDepartment of Clinical and Experimental Medicine (IKE), Division of Cell Biology, and Integrative Regenerative Medicine Center (IGEN), Linköping University, Linköping Sweden.
Joanna Rzeszowska-WolnyInst. of Automatic Control, Silesian Univ. of Technology, Gliwice, Poland.
Mehrdad RafatDepartment of Biomedical Engineering, Linköping University, Linköping Sweden.
Joerg StetefeldDepartment of Chemistry, University of Manitoba, Winnipeg, Canada.
Saeid GhavamiDepartment of Human Anatomy and Cell Science, University of Manitoba, Winnipeg, Canada.
Marek J LosDepartment of Clinical and Experimental Medicine (IKE), Division of Cell Biology, and Integrative Regenerative Medicine Center (IGEN), Linköping University, Linköping Sweden; Department of Pathology, Pomeranian Medical University, Szczecin, Poland. Electronic address: marek.los@liu.se.
Linköping University · SEUniversity of Manitoba · CASilesian University of Technology · PLTunis University · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human gyrovirus derived protein Apoptin (HGV-Apoptin) a homologue of the chicken anemia virus Apoptin (CAV-Apoptin), a protein with high cancer cells selective toxicity, triggers apoptosis selectively in cancer cells. In this paper, we show that HGV-Apoptin acts independently from the death receptor pathway as it induces apoptosis in similar rates in Jurkat cells deficient in either FADD (fas-associated death domain) function or caspase-8 (key players of the extrinsic pathway) and their parental clones. HGV-Apoptin induces apoptosis via the activation of the mitochondrial intrinsic pathway. It induces both mitochondrial inner and outer membrane permebilization, characterized by the loss of the mitochondrial potential and the release into cytoplasm of the pro-apoptotic molecules including apoptosis inducing factor and cytochrome c. HGV-Apoptin acts via the apoptosome, as lack of expression of apoptotic protease-activating factor 1 in murine embryonic fibroblast strongly protected the cells from HGV-Apoptin-induced apoptosis. Moreover, QVD-oph a broad-spectrum caspase inhibitor delayed HGV-Apoptin-induced death. On the other hand, overexpression of the anti-apoptotic BCL-XL confers resistance to HGV-Apoptin-induced cell death. In contrast, cells that lack the expression of the pro-apoptotic BAX and BAK are protected from HGV-Apoptin induced apoptosis. Furthermore, HGV-Apoptin acts independently from p53 signal but triggers the cytoplasmic translocation of Nur77. Taking together these data indicate that HGV-Apoptin acts through the mitochondrial pathway, in a caspase-dependent manner but independently from the death receptor pathway.

Indexed as

ApoptosisSignal TransductionApoptosis Inducing FactorCaspasesCell LineCytochromes cCytoplasmGyrovirusHumansMembrane Potential, MitochondrialMitochondriaModels, BiologicalNuclear Receptor Subfamily 4, Group A, Member 1Protein TransportProto-Oncogene Proteins c-bcl-2Receptors, Death DomainAIFM1 protein, humanApoptosis Inducing FactorCaspasesCytochromes cNuclear Receptor Subfamily 4, Group A, Member 1Proto-Oncogene Proteins c-bcl-2Receptors, Death DomainViral Proteins

Identifiers

PMID25246270
PMCPMC4234882
OpenAlexW1996527323

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.